Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration

Retina

Volumn 20, Issue 3, 2000, Pages 251-256

  Krepler, Katharina ^a   Kruger, Andreas ^b   Tittl, Michael ^b   Stur, Michael ^b   Wedrich, Andreas ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Age related macular degeneration; Subretinal hemorrhage; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FLUORESCEIN; INDOCYANINE GREEN; SULFUR HEXAFLUORIDE;

AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LASER COAGULATION; MALE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 0033917887     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200003000-00005     Document Type: Article

References (19)

1. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990;109:33-37.
2. Avery RL, Fekrat S, Hawkin BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-189.
3. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97-102.
4. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-772.
5. Toth CA, Morse LS, Hjelmeland LM, Landers MB. Fibrin directs early damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109:723-729.
6. Ohji MO, Saito Y, Hayashi A, et al. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-1332.
7. de Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-29.
8. Wade EC, Flynn HW, Olsen KR, et al. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 1990;108:973-978.
9. Scheider A, Gündisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefes Arch Clin Exp Ophthalmol 1999;237:10-15.
10. Lewis HL. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-568.
11. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye 1995;9:582-588.
12. Kimura AE, Chittaranjan F, Folk JC, Farmer SG. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator. Retina 1994;14:83-84.
13. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-263.
14. Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res 1985;40: 687-696.
15. Takeuchi A, Kricorian G, Yao XY, et al. The rate and source of albumin entry into saline-filled experimental retinal detachment. Invest Ophthalmol Vis Sci 1994;35:3792-3798.
16. Boone DE, Boldt CH, Ross RD, et al. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina 1996;16:518-524.
17. Coll GE, Sparrow JR, Marinovic A, Chang S. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina 1995;15:319-326.
18. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-277.
19. Berrocal MH, Lewis ML, Flynn HW. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996; 122:486-493.